In short, GLP-1 receptor agonists now occupy a leading position among the worlds best-selling medicines , reflecting unprecedented demand for these new diabetes and obesity treatments
The North America GLP-1 receptor agonist market dominated the revenue with 75.46% share in 2025, supported by a high prevalence of metabolic disorders, early adoption of novel therapeutics, and a well-established healthcare infrastructure
Plant Cell Physiol 33:541553 Mller IM, Jensen PE, Hansson A (2007) Oxidative modifications to cellular components in plants
Going barefoot on hard surfaces, wearing flat shoes without support, or spending extended time in worn-out footwear can undermine healing progress even with peptide therapy
a systematic review and meta-analysis
This balance underscores why multiple trial arms were necessary: without testing a range of dosages, investigators would not have uncovered these differences in outcome patterns